Mandadi Tilak (CIK 1872827) reported 7 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-11). Recent activity: Sell CVS (69,551 shares), Buy CVS (22,277 shares), Sell CVS (3,634 shares), Sell CVS (6,575 shares), Sell CVS (12,834 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-11 | CVS HEALTH Corp (CVS) | EVP, Chief Exp & Tech Officer | Sell | 69,551 | $6.2M |
| 2026-04-02 | CVS HEALTH Corp (CVS) | EVP, Chief Exp & Tech Officer | Buy | 22,277 | $1.6M |
| 2026-04-02 | CVS HEALTH Corp (CVS) | EVP, Chief Exp & Tech Officer | Sell | 3,634 | $263,429 |
| 2025-12-02 | CVS HEALTH Corp (CVS) | EVP, Chief Exp & Tech Officer | Sell | 6,575 | $528,367 |
| 2025-09-02 | CVS HEALTH Corp (CVS) | EVP, Chief Exp & Tech Officer | Sell | 12,834 | $938,807 |
| 2025-04-03 | CVS HEALTH Corp (CVS) | EVP, Chief Experience & Tech | Sell | 995 | $67,640 |
| 2025-04-03 | CVS HEALTH Corp (CVS) | EVP, Chief Experience & Tech | Buy | 20,594 | $1.4M |
Source: SEC Form 4 filings · as of 2026-05-11